Results 101 to 110 of about 299,956 (159)

Radiomics in distinguishing between lung adenocarcinoma and lung squamous cell carcinoma: a systematic review and meta-analysis. [PDF]

Front Oncol
Shi L, Zhao J, Wei Z, Wu H, Sheng M.
europepmc   +1 more source

Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma. [PDF]

Oncol Lett, 2021
Cao B, Wang P, Gu L, Liu J.
europepmc   +1 more source

Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. [PDF]

Cancer Manag Res
Nu Er Lan STE, Yu B, Yang Y, Shen Y, Xu B, Zhan Y, Liu C.   +6 more
europepmc   +1 more source

Posterior Subglottic Mass in a Patient With a History of Rectal Adenocarcinoma and Lung Metastases. [PDF]

JAMA Oncol, 2020
Craig F, O'Sullivan Coyne G, Allen CT.
europepmc   +1 more source

Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile. [PDF]

J Cell Mol Med, 2021
Deng S, Lu X, Zhang Z, Meng R, Li M, Xia S.   +5 more
europepmc   +1 more source

Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. [PDF]

Genes Dis
Shen Y, Chen JQ, Li XP.
europepmc   +1 more source

Mesenchymal-epithelial transition factor exon 14 skipping mutation-positive granulocyte colony-stimulating factor-producing lung adenocarcinoma mimicking lung abscess: A case report. [PDF]

Respirol Case Rep
Izumiya Y, Odaka H, Kikuchi T, Takita Y, Tokairin T.   +4 more
europepmc   +1 more source

A rare case of secondary pulmonary alveolar proteinosis with adenocarcinoma of lung with retroviral disease. [PDF]

Lung India, 2020
Punwani AD, Karpe SP, Athavale AU, Garg PD, Jansari MR.   +4 more
europepmc   +1 more source

In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma. [PDF]

Front Oncol
Wang X, Zheng K, Hao Z.
europepmc   +1 more source

Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study. [PDF]

EClinicalMedicine
Pu X, Lin G, Xiao M, Lin J, Wang Q, Kong Y, Yan X, Xu F, Xu Y, Li J, Li K, Chen B, Wen X, Tan Y, Cheng F, Zhu K, Li N, Wu L.   +17 more
europepmc   +1 more source